The increasing prevalence of insomnia globally, driven by heightened stress levels, has significantly contributed to the expansion of the insomnia therapeutics market. This growth is further supported by an aging population and a growing awareness of various available therapies and treatments. Advances in technology have led to the development of more effective therapies that deliver quick, positive results, making the public more receptive to these solutions.